Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 1, 2010, Pages 153-163

  Pousinha, Paula A ^a,b   Correia, Alexandra M ^a,b   Sebastião, Ana M ^a,b   Ribeiro, Joaquim Alexandre ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE KINASE;

ACETYLCHOLINE RELEASE; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAPHRAGM; ENDPLATE POTENTIAL; ENZYME INHIBITION; EVOKED RESPONSE; FACILITATION; MALE; MUSCLE CELL; MUSCLE INNERVATION; NEUROMODULATION; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

2-CHLOROADENOSINE; ADENOSINE; ANIMALS; DIAPHRAGM; EXCITATORY POSTSYNAPTIC POTENTIALS; INHIBITORY POSTSYNAPTIC POTENTIALS; LIGANDS; MALE; MINIATURE POSTSYNAPTIC POTENTIALS; NEUROMUSCULAR JUNCTION; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; TUBERCIDIN;

EID: 73949099409     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.157255     Document Type: Article

References (35)

1. Arch J and Newsholme E (1978) The control of metabolism and the hormonal role of adenosine. Essays in Biochemistry (Campbell PN and Aldridge WN eds), pp 82-123, Academic Press, New York.
2. Ciruela F, Casadó V, Rodrigues RJ, Luján R, Burgueño J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26: 2080-2087.
3. Correia-de-Sá P and Ribeiro JA (1994) Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol 350:514-522.
4. Correia-de-Sá P and Ribeiro JA (1996) Adenosine uptake and deamination regulate tonic A2A receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals. Neuroscience 73:85-92.
5. Correia-de-Sá P, Sebastião AM, and Ribeiro JA (1991) Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol 103:1614-1620.
6. Cunha RA and Sebastião AM (1991) Extracellular metabolism of adenine nucleotides and adenosine in the innervated skeletal muscle of the frog. Eur J Pharmacol 197:83-92.
7. Cunha RA and Sebastião AM (1993) Adenosine and adenine nucleotides are independently released from both the nerve terminals and the muscle fibres upon electrical stimulation of the innervated skeletal muscle of the frog. Pflugers Arch 424:503-510.
8. Cunha RA, Correia-de-Sá P, Sebastião AM, and Ribeiro JA (1996a) Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br J Pharmacol 119:253-260.
9. Cunha RA, Johansson B, Constantino MD, Sebastião AM, and Fredholm BB (1996b) Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn Schmiedebergs Arch Pharmacol 353:261-271.
10. Cunha RA, Johansson B, van der Ploeg I, Sebastião AM, Ribeiro JA, and Fredholm BB (1994) Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res 649:208-216.
11. Daly JW (1982) Adenosine receptors: targets for future drugs. J Med Chem 25:197-207.
12. Fatt P and Katz B (1951) An analysis of the end-plate potential recorded with an intracellular electrode. J Physiol 115:320-370.
13. Franco R, Casadó V, Cortés A, Pérez-Capote K, Mallol J, Canela E, Ferré S, and Lluis C (2008) Novel pharmacological targets based on receptor heteromers. Brain Res Rev 58:475-482.
14. Giri S, Nath N, Smith B, Viollet B, Singh AK, and Singh I (2004) 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci 24:479-487.
15. Ginsborg BL and Hirst GD (1972) The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol 224:629-645.
16. Jacobson KA, van Galen PJ, and Williams M (1992) Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35:407-422.
17. Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, and Williams M (1989) [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther 251:888-893.
18. Jarvis SM, Martin BW, and Ng AS (1985) 2-Chloroadenosine, a permeant for the nucleoside transporter. Biochem Pharmacol 34:3237-3241.
19. Katz B (1969) The Release of Neurotransmitter Substances, pp 11-12, Charles C Thomas, Springfield, IL.
20. Klein H, Garneau L, Trinh NT, Privé A, Dionne F, Goupil E, Thuringer D, Parent L, Brochiero E, and Sauvé R (2009) Inhibition of the KCa3.1 channels by AMPactivated protein kinase in human airway epithelial cells. Am J Physiol Cell Physiol 296:C285-C295.
21. Kowaluk EA, Bhagwat SS, and Jarvis MF (1998) Adenosine kinase inhibitors. Curr Pharm Des 4:403-416.
22. Lopes LV, Cunha RA, Kull B, Fredholm BB, and Ribeiro JA (2002) Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112:319-329.
23. Lupica CR, Cass WA, Zahniser NR, and Dunwiddie TV (1990) Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther 252:1134-1141.
24. Menrath R and Blackman J (1970) Observations on the large spontaneous potentials which occur at endplates of the rat diaphragm. Proc Univ Otago Med Sch 48: 72-73.
25. Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, and Goodyear LJ (2001) AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280:E677-E684.
26. Poucher SM, Keddie JR, Singh P, Stoggall SM, Caulkett PW, Jones G, and Coll MG (1995) The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102.
27. Pousinha PA, Sebastião AM, and Ribeiro J (2007) A predominance of A2A receptors on adenosine effects at the rat diaphragm neuromuscular junction, in 2007 Abstract Viewer/Itinerary Planner; 2007 Nov 3-7; San Diego, CA. Program no. 680.8/ G6, Society for Neuroscience, Washington, DC.
28. Ribeiro JA and Sebastião AM (1985) On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol 84:911-918.
29. Ribeiro JA and Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54:213-218.
30. Sebastião AM and Ribeiro JA (1988) On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol 94: 109-120.
31. Sebastião AM and Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21:341-346.
32. Sebastião AM, Stone TW, and Ribeiro JA (1990) The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol 101:453-459.
33. Silinsky EM (1975) On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J Physiol 247: 145-162.
34. Smith DO (1991) Sources of adenosine released during neuromuscular transmission in the rat. J Physiol 432:343-354.
35. Yeung SM, Fossom LH, Gill DL, and Cooper DM (1985) Magnesium ion exerts a central role in the regulation of inhibitory adenosine receptors. Biochem J 229: 91-100.